Boehringer Ingelheim has announced an increase in sales for full year 2018, but a slight decline in profits, as price competition began to affect its biggest selling drug Spiriva. The German pharma's ...
As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO. Formerly the ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Inhaler colors often help identify the type of medication inside but there is no standard color code. Rescue inhalers are fast-acting and provide quick relief for acute symptoms. Preventer inhalers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback